##  [China: National Adverse Drug Reaction Monitoring Annual Report (2025)](/index%2Ephp/mandate/china-national-adverse-drug-reaction-monitoring-annual-report-2025) 

April 27, 2026

China released its 2025 national adverse drug reaction monitoring report, highlighting key pharmacovigilance trends and post-market safety monitoring activities.

**Key highlights:**

- Provides insights into adverse event reporting trends
- Highlights post-marketing safety monitoring priorities
- Supports stronger pharmacovigilance compliance
- Helps manufacturers improve risk management strategies

This update is important for companies managing post-market drug safety requirements.



[Consult Now](/webform/consult%0A?url=https://www.freyrsolutions.com/index%2Ephp/markdownify/node/13335)



Source

<https://www.cdr-adr.org.cn/center_news/202604/t20260427_51496.html>

<https://www.cdr-adr.org.cn/yjj_center_news/>

 

 

Select Mandate HA

[NMPA](/index%2Ephp/mandate-by-ha/nmpa)

 

Select Mandate Function

[Regulatory Affairs](/index%2Ephp/mandate-by-function/regulatory-affairs)